128 related articles for article (PubMed ID: 31262833)
21. Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.
Suresh K; Kliot T; Piunti A; Kliot M
Surg Neurol Int; 2016; 7(Suppl 33):S797-S800. PubMed ID: 27920939
[TBL] [Abstract][Full Text] [Related]
22. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
[TBL] [Abstract][Full Text] [Related]
23. Low-Grade Malignant Peripheral Nerve Sheath Tumor Mimicking Schwannoma: Role and Importance of Trimethylated H3K27M Staining.
Gilder HE; Puffer RC; Spinner RJ; Raghunathan A; Bydon M
World Neurosurg; 2018 Sep; 117():178-181. PubMed ID: 29909207
[TBL] [Abstract][Full Text] [Related]
24. PRC2 loss drives MPNST metastasis and matrix remodeling.
Brockman QR; Scherer A; McGivney GR; Gutierrez WR; Voigt AP; Isaacson AL; Laverty EA; Roughton G; Knepper-Adrian V; Darbro B; Tanas MR; Stipp CS; Dodd RD
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36066973
[TBL] [Abstract][Full Text] [Related]
25. Honokiol: Treatment for malignant peripheral nerve sheath tumors.
Joshi MR
J Cancer Res Ther; 2023; 19(5):1485-1486. PubMed ID: 37787339
[No Abstract] [Full Text] [Related]
26. [Advances in malignant peripheral nerve sheath tumor].
Peng W; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):288-292. PubMed ID: 33677903
[TBL] [Abstract][Full Text] [Related]
27. PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.
Patel AJ; Warda S; Maag JLV; Misra R; Miranda-Román MA; Pachai MR; Lee CJ; Li D; Wang N; Bayshtok G; Fishinevich E; Meng Y; Wong EWP; Yan J; Giff E; Pappalardi MB; McCabe MT; Fletcher JA; Rudin CM; Chandarlapaty S; Scandura JM; Koche RP; Glass JL; Antonescu CR; Zheng D; Chen Y; Chi P
Cancer Discov; 2022 Sep; 12(9):2120-2139. PubMed ID: 35789380
[TBL] [Abstract][Full Text] [Related]
28. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.
Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ
J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317
[TBL] [Abstract][Full Text] [Related]
29. Shaping Our Understanding of Malignant Peripheral Nerve Sheath Tumor: A Bibliometric Analysis of the 100 Most-Cited Articles.
Rechberger JS; Millesi E; Power EA; Wang H; Mardini S; Spinner RJ; Daniels DJ
World Neurosurg; 2024 Apr; 184():293-302.e11. PubMed ID: 38219800
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Clinical, Histopathological, and Genomic Features Between Malignant Peripheral Nerve Sheath Tumors and Cellular Schwannomas of the Eighth Cranial Nerve: A Case Series.
Zhao F; Zhang S; Du J; Chen Y; Wang B; Zhang J; He Q; Lin L; Zhang L; Yu Y; Liu P
World Neurosurg; 2019 Feb; 122():e487-e497. PubMed ID: 30366145
[TBL] [Abstract][Full Text] [Related]
31. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.
Plaat BE; Molenaar WM; Mastik MF; Hoekstra HJ; te Meerman GJ; van den Berg E
Int J Cancer; 1999 Oct; 83(2):171-8. PubMed ID: 10471523
[TBL] [Abstract][Full Text] [Related]
32. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
[TBL] [Abstract][Full Text] [Related]
33. [PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex].
Luscan A; Vidaud D; Ortonne N; Wolkenstein P; Vidaud M; Pasmant E
Med Sci (Paris); 2014; 30(8-9):733-5. PubMed ID: 25174745
[No Abstract] [Full Text] [Related]
34. [Metastatic malignant neurinoma (neurinosarcoma-neurofibrosarcoma) of the small pelvis].
ZEISS KH
Zentralbl Allg Pathol; 1955 Sep; 94(3-4):189-94. PubMed ID: 13282424
[No Abstract] [Full Text] [Related]
35. The implications of intradural extension in paraspinal malignant peripheral nerve sheath tumors: effects on central nervous system metastases and overall survival.
Gilder HE; Puffer RC; Bydon M; Spinner RJ
J Neurosurg Spine; 2018 Dec; 29(6):725-728. PubMed ID: 30239270
[TBL] [Abstract][Full Text] [Related]
36. Advancements in therapeutic approaches for malignant peripheral nerve sheath tumor.
Millesi E; Rechberger JS; Wang H; Mardini S; Spinner RJ; Daniels DJ
Ther Deliv; 2023 Jun; 14(6):385-389. PubMed ID: 37464750
[TBL] [Abstract][Full Text] [Related]
37. Malignant Peripheral Nerve Sheath Tumor.
James AW; Shurell E; Singh A; Dry SM; Eilber FC
Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.
Young ED; Ingram D; Metcalf-Doetsch W; Khan D; Al Sannaa G; Le Loarer F; Lazar AJF; Slopis J; Torres KE; Lev D; Pollock RE; McCutcheon IE
J Neurosurg; 2018 Sep; 129(3):805-814. PubMed ID: 28885122
[TBL] [Abstract][Full Text] [Related]
39. Immune system evasion by peripheral nerve sheath tumor.
Lee PR; Cohen JE; Fields RD
Neurosci Lett; 2006 Apr 10-17; 397(1-2):126-9. PubMed ID: 16406348
[TBL] [Abstract][Full Text] [Related]
40. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors.
Zhang M; Wang Y; Jones S; Sausen M; McMahon K; Sharma R; Wang Q; Belzberg AJ; Chaichana K; Gallia GL; Gokaslan ZL; Riggins GJ; Wolinksy JP; Wood LD; Montgomery EA; Hruban RH; Kinzler KW; Papadopoulos N; Vogelstein B; Bettegowda C
Nat Genet; 2014 Nov; 46(11):1170-2. PubMed ID: 25305755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
